Cargando…

Evaluation of chemiluminescent immunoassay quantitative detection for pro-gastrin-releasing peptide (ProGRP) in serum and plasma

OBJECTIVE: To evaluate a newly developed Hybiome ProGRP chemiluminescent assay. METHODS: Analytical sensitivity, precision, recovery, and equivalency of serum and plasma, serum stability, and complement interference of the Hybiome ProGRP assay were evaluated. Serum specimens from 318 individuals inc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yizhuang, He, Jing, Zhang, Liping, Chen, Xiufa, Ou, Saiying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607052/ https://www.ncbi.nlm.nih.gov/pubmed/31856626 http://dx.doi.org/10.1177/0300060519882802

Ejemplares similares

Pro-gastrin-releasing peptide (ProGRP) as a biomarker in small-cell lung cancer diagnosis, monitoring and evaluation of treatment response
por: Wojcik, Ewa, et al.
Publicado: (2017)

Utility of the Serum ProGRP Level for Follow-up of Pulmonary Carcinoid Tumors
por: Taira, Naohiro, et al.
Publicado: (2014)

ProGRP与NSE对小细胞肺癌诊断价值的meta分析
Publicado: (2010)

Detection of CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and Their Relationship with CT Signs
por: Tian, Kui, et al.
Publicado: (2022)

Gastrin-Releasing Peptide (GRP) Stimulates Osteoclastogenesis in Periodontitis
por: Choi, YunJeong, et al.
Publicado: (2020)

血清NSE、ProGRP和LDH在小细胞肺癌诊断治疗中的作用
Publicado: (2016)

Detection of Changes in CEA and ProGRP Levels in BALF of Patients with Peripheral Lung Cancer and the Relationship with CT Signs
por: Huang, Jingshan, et al.
Publicado: (2023)

High Sensitive Immunoelectrochemical Measurement of Lung Cancer Tumor Marker ProGRP Based on TiO(2)-Au Nanocomposite
por: Wei, Zheng, et al.
Publicado: (2019)

Evaluating the diagnostic and prognostic value of serum TuM2‐PK, NSE, and ProGRP in small cell lung cancer
por: Li, Li, et al.
Publicado: (2023)

Plasma proGRP Concentration is Sensitive and Specific for Discriminating Small Cell Lung Cancer from Nonmalignant Conditions or Non-small Cell Lung Cancer
por: Kim, Hye-Ran, et al.
Publicado: (2011)

Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023)

The influence of different blood samples treatment methods on pro-gastrin-releasing peptide
por: Jiang, Huiqin, et al.
Publicado: (2019)

Effects of Bevacizumab Combined with Chemotherapy on CT, CyFRA21-1, and ProGRP and Prognosis of Lung Cancer Patients under Nursing Intervention
por: Xi, Chao, et al.
Publicado: (2022)

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer
por: Nisman, Benjamin, et al.
Publicado: (2016)

ProGRP as early predictive marker of non–small-cell lung cancer to small-cell lung cancer transformation after EGFR-TKI treatment
por: Kato, Yasuhiro, et al.
Publicado: (2019)

Retracted: Effects of Bevacizumab Combined with Chemotherapy on CT, CyFRA21-1, and ProGRP and Prognosis of Lung Cancer Patients under Nursing Intervention
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Central ventilatory and cardiovascular actions of trout gastrin-releasing peptide (GRP) in the unanesthetized trout
por: Le Mével, Jean-Claude, et al.
Publicado: (2013)

Afatinib Targeted Therapy Affects the Immune Function and Serum Levels of EGFR and Gastrin-Releasing Peptide Precursor (pro-GRP) in Patients with Non-Small-Cell Lung Cancer (NSCLC)
por: Cao, Wei, et al.
Publicado: (2022)

Pulmonary carcinoid tumour with remarkably high levels of pro-gastrin-releasing peptide: A case report
por: Nakagawa, Natsuki, et al.
Publicado: (2023)

Targeting the Gastrin-Releasing Peptide Receptor (GRP-R) in Cancer Therapy: Development of Bombesin-Based Peptide–Drug Conjugates
por: Gomena, Jacopo, et al.
Publicado: (2023)

一项在欧洲和中国进行的新型胃泌素释放肽前体（ProGRP）免疫检测多中心评估研究
por: KORSE, Catharina M., et al.
Publicado: (2017)

Pro‐gastrin‐releasing peptide and outcome in patients with heart failure and anaemia: results from the RED‐HF study
por: Ueland, Thor, et al.
Publicado: (2018)

Paclitaxel-loaded nanobubble targeted to pro-gastrin-releasing peptide inhibits the growth of small cell lung cancer
por: Wang, Jin-Ping, et al.
Publicado: (2019)

Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma
por: Miao, Qiang, et al.
Publicado: (2023)

Serum ProGRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer: A case report
por: Oya, Yuko, et al.
Publicado: (2018)

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist (68)Ga-NODAGA-MJ9
por: Gnesin, Silvano, et al.
Publicado: (2018)

Algorithm using Neuron-Specific Enolase and Pro-Gastrin-Releasing Peptide to Increase the Diagnostic Accuracy for Small Cell Lung Cancer
por: Lee, Haeyoung, et al.
Publicado: (2021)

Negative Interference by Rheumatoid Factor of Plasma B-Type Natriuretic Peptide in Chemiluminescent Microparticle Immunoassays
por: Fan, Wen, et al.
Publicado: (2014)

Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors
por: Accardo, Antonella, et al.
Publicado: (2016)

Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase.
por: Takada, M., et al.
Publicado: (1996)

Enzyme‐linked Immunosorbent Assay of Pro‐gastrin‐releasing Peptide for Small Cell Lung Cancer Patients in Comparison with Neuron‐specific Enolase Measurement
por: Yamaguchi, Ken, et al.
Publicado: (1995)

Development of an Automated Chemiluminescent Enzyme Immunoassay for Measuring Thrombopoietin in Human Plasma
por: Nishikawa, Yukihiro, et al.
Publicado: (2022)

Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis
por: Pendharkar, Sayali A., et al.
Publicado: (2017)

Analgesic effect of gastrin-releasing peptide in the dorsal horn
por: Saeki, Ayano, et al.
Publicado: (2022)

Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist (68)Ga-RM2 and (18)F-FDG in breast cancer samples
por: Morgat, Clément, et al.
Publicado: (2019)

A quantitative detection of Cardiotrophin‐1 in chronic heart failure by chemiluminescence immunoassay
por: Ping, Ying, et al.
Publicado: (2021)

Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis
por: Green, Paul G
Publicado: (2005)

How Gastrin-Releasing Peptide Opens the Spinal Gate for Itch
por: Pagani, Martina, et al.
Publicado: (2019)

Nanostrategies for Therapeutic and Diagnostic Targeting of Gastrin-Releasing Peptide Receptor
por: Rurarz, Beata Paulina, et al.
Publicado: (2023)

Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer
por: Ueki, Kazuhito, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_upj46m511037cid7b5344107p5